Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma. | Cell Rep Med | 2024 | 38776914 | PubTator, text mining | PubMed |
| Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders. | ACS Med Chem Lett | 2024 | 38746898 | PubTator, text mining | PubMed |
| Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library. | bioRxiv | 2024 | 38746375 | PubTator, text mining | PubMed |
| Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells. | J Med Chem | 2024 | 38745549 | PubTator, text mining | PubMed |
| Development of Peptide Displacement Assays to Screen for Antagonists of DDB1 Interactions. | Biochemistry | 2024 | 38729622 | PubTator, text mining | PubMed |
| Towards the Targeted Protein Degradation of PRMT1. | ChemMedChem | 2024 | 38724444 | PubTator, text mining | PubMed |
| MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance. | Clin Cancer Res | 2024 | 38723281 | PubTator, text mining | PubMed |
| Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer Agents. | Drug Discov Today | 2024 | 38704021 | PubTator, text mining | PubMed |
| Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents. | J Med Chem | 2024 | 38690687 | PubTator, text mining | PubMed |
| Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader. | J Med Chem | 2024 | 38687638 | PubTator, text mining | PubMed |
| Coordination among frequent genetic variants imparts substance use susceptibility and pathogenesis. | Front Neurosci | 2024 | 38660223 | PubTator, text mining | PubMed |
| Inhibitors to degraders: Changing paradigm in drug discovery. | iScience | 2024 | 38646175 | PubTator, text mining | PubMed |
| Native mass spectrometry of complexes formed by molecular glues reveals stoichiometric rearrangement of E3 ligases. | Analyst | 2024 | 38639441 | PubTator, text mining | PubMed |
| Expanding the ligand spaces for E3 ligases for the design of protein degraders. | Bioorg Med Chem | 2024 | 38621319 | PubTator, text mining | PubMed |
| Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma. | Cancers (Basel) | 2024 | 38610997 | PubTator, text mining | PubMed |
| SuFEx-based chemical diversification for the systematic discovery of CRBN molecular glues. | Bioorg Med Chem | 2024 | 38608634 | PubTator, text mining | PubMed |
| Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader. | J Med Chem | 2024 | 38607318 | PubTator, text mining | PubMed |
| Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs): A Modular Platform for Generating Reversible, Self-Assembling Bifunctional Targeted Degraders. | J Med Chem | 2024 | 38554135 | PubTator, text mining | PubMed |
| Crbn-based molecular Glues: Breakthroughs and perspectives. | Bioorg Med Chem | 2024 | 38552596 | PubTator, text mining | PubMed |
| Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode. | Eur J Med Chem | 2024 | 38552426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=21